Business · 08/03/2001
FDA Releases Guidance for Levothyroxine Sodium Drug Products
The Food and Drug Administration (FDA) has made available a guidance document addressing questions and concerns related to the approval of levothyroxine sodium drug products, specifically those administered orally.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →